John Charles Canning, Chief Operating Officer at FEMASYS INC (FEMY), bought 4,375 shares at $3.20 ($14K) on 2026-08-07, disclosed to the SEC on 2026-08-11.
FEMASYS COO Canning John Charles purchased 4,375 shares for $14,000 at $3.20, signaling confidence in the company despite recent stock declines. This insider buying comes as the stock trades near its 52-week low of $0.3067, potentially indicating a value play.
The stock is down 26.73% over the past year and is currently trading 48.82% below its 52-week high of $1.11, while sitting 85.23% above its 52-week low of $0.3067.
A partnership announced on September 23, 2025, with Medical Electronic Systems to expand the FemSperm product family could drive future revenue growth.
The company is currently trading at a forward P/E of -0.405, indicating losses, and faces dilution risk following a $8 million public offering in August 2025.
Clearly above the average filing.